VETERINARY MEDICINE MARKET ANALYSIS

Name: Veterinary Medicine Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Veterinary Medicine Market, By Animal Type (Domesticated and Companion), By Product (Drug and Vaccines), By Route of Administration (Oral, Parental, and Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Stores, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Global Veterinary Medicine Market: Key Developments

In September 2022, the U.S. Food and Drug Administration (FDA) approved SpectoGard, the first generic spectinomycin sulfate injectable solution for the treatment of bovine respiratory diseases.
In June 2022, the Food and Drug Administration (FDA) approved Vetmedin-CA1 (pimobendan) chewable tablets, the first medication intended for delaying the onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease.
In March 2022, Vetcare Oy received the U.S. Food and Drug Administration (FDA) approval for Zenalpha, for the use as a sedative and analgesic in dogs to facilitate clinical examination, clinical procedures, and minor surgical procedures.
In August 2021, Ethos and National Veterinary Associates team up to develop advanced veterinary medicines for patients and their families and to enhance service offerings with advancements in medical care.